Research and development - Press Releases

Date	Title	Company
13-Jul-2023	Landmark study demonstrates economic edge of precision medicine that we can’t afford to ignore	Diaceutics Plc
13-Jul-2023	New Business Support Programme and Competition for Life Science Startups - Discovery Spark	Discovery Park
12-Jul-2023	Vivan Therapeutics, the Institute for Cancer Research and IDIBELL form new AI drug discovery collaboration to design new precision cancer drugs	Vivan Therapeutics
11-Jul-2023	Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production	Kindeva Drug Delivery
11-Jul-2023	Sosei Heptares Webinar Presentation for Q2 FY2023 Financial Results	Sosei Group Corporation
11-Jul-2023	KFSH&RC Implants Brain Electrodes in Child to Detect Epileptic Foci Without Surgery for First Time in Middle East	King Faisal Specialist Hospital and Research Center (KFSH&RC)
11-Jul-2023	Eremid® Genomic Services expands long-read HiFi sequencing capabilities with PacBio Revio	Eremid® Genomic Services
11-Jul-2023	Rapid UTI test launched after new figures reveal eight million hours wasted on GP visits costing the NHS nearly £300m every year	newfoundland
11-Jul-2023	Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure	Sequana Medical
11-Jul-2023	Recommendations from Imperial College London to improve UK’s competitiveness in critical industries	Imperial College London
10-Jul-2023	Domainex expands its research operations by securing from Howard Group a new facility at Unity Campus	Sciad Newswire
07-Jul-2023	Alfa Chemistry: Environmental Standards to Achieve Fast and Accurate Environmental Analysis	Alfa Chemistry
06-Jul-2023	Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models	Qkine
06-Jul-2023	1,000th alfapump® implant completed	Sequana Medical NV
06-Jul-2023	How do we all spend our time? Brits spend 2 hours a day watching TV but just 20 minutes keeping fit	London Medical Laboratory
06-Jul-2023	F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies	F-star Therapeutics
06-Jul-2023	Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals	Pheon Therapeutics
06-Jul-2023	Oxford BioTherapeutics Initiates Phase Ib Clinical Trial for OBT076 in Patients with Advanced Solid Tumors by Dosing First Patient in Combination with CPI Balstilimab in Europe	Oxford BioTherapeutics
06-Jul-2023	Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform	Biocomposites
06-Jul-2023	New Analysis of MRI Findings Shows UPLIZNA® (inebilizumab) Reduced the Formation of Subclinical Spinal Cord Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)	Horizon Therapeutics plc